TL
TLSIW
TriSalus Life Sciences, Inc.
$0.7500
0.00%
$46.1M
No data for this timeframe.
Vol
Market Cap$46.1M
Cap SizeNano Cap
Inst. Holders4 funds
Inst. Value$1.1M
Inst. Activity1 buys / 1 sells
SEC Reports2
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001826667·Prev Close $0.7500
Recent Activity
Apr 29, 2026
SEC
TriSalus Life Sciences disclosed the planned retirement of Chief of Clinical Operations Jodi Devlin, effective October 1
8-K — Impact 2/10
Apr 7, 2026
SEC
TriSalus Life Sciences appointed Dr. Richard Marshall as Chief Medical Officer, effective June 29, 2026. He transitions
8-K — Impact 3/10
Inst.
CITADEL ADVISORS LLC — DOUBLED
126,876 shares ($199.2K)
Inst.
TORONTO DOMINION BANK — TRIM
5,170 shares ($8.5K)
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| Cerity Partners LLC | $993.1K | — |
| CITADEL ADVISORS LLC | $78.2K | DOUBLED |
| TORONTO DOMINION BANK | $6.5K | TRIM |
| Rockefeller Capital Management L.P. | $60.00 | — |
4 institutional holders with $1.1M total value (898,000 shares) as of 2026-Q1. Top holders: Cerity, CITADEL, TORONTO.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | Cerity Partners LLC | 827,590 | $993.1K | 92.1% | — |
| 2 | CITADEL ADVISORS LLC | 65,190 | $78.2K | 7.3% | DOUBLED +439.0% |
| 3 | TORONTO DOMINION BANK | 5,170 | $6.5K | 0.6% | TRIM -44.9% |
| 4 | Rockefeller Capital Management L.P. | 50 | $60.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | DOUBLED | 23,540 | 126,876 | +439.0% | $199.2K | 2025-Q3 |
| TORONTO DOMINION BANK | TRIM | 9,383 | 5,170 | -44.9% | $8.5K | 2025-Q3 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 13,900 | 8,735 | -37.2% | $10.6K | 2025-Q1 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 2.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -8.4% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 26.4% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 16.0% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 49.7% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.